# Ryaltris

NDC: 68462-659
Generic name: olopatadine hydrochloride and mometasone furoate
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY, METERED
Routes: NASAL
Marketing started: 20260113

FDA application: NDA211746

## Active ingredients

- MOMETASONE FUROATE MONOHYDRATE: 25 ug/1
- OLOPATADINE HYDROCHLORIDE: 665 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-659"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-659
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=406be932-f00e-4c66-9dd1-c142090fe822